Senseonics Partners with Welldoc to Overhaul Eversense 365 App

Event summary

  • Senseonics and Welldoc announce a strategic partnership to develop a next-generation app for the Eversense 365 CGM system.
  • The new app will enhance user experience and integrate with Apple Health and Google Health Connect.
  • Expected launch in the U.S. in the second half of 2026, with European availability early 2027.
  • Future releases may include AI-powered features like bolus calculation and medication management.

The big picture

This partnership aligns with the broader trend of digital health companies leveraging AI to enhance chronic disease management. Senseonics aims to differentiate its implantable CGM system through improved app functionality, while Welldoc expands its footprint in diabetes care. The collaboration could set a new standard for CGM app interoperability and user experience.

What we're watching

Integration Success
How seamless integration with Apple Health and Google Health Connect will impact user adoption and engagement.
AI Enhancements
Whether Welldoc’s AI-powered platform can deliver meaningful improvements in CGM-informed bolus calculation and medication management.
Market Expansion
The pace at which the new app can drive adoption in European markets after its U.S. launch.

Related topics

Partnership